Clinical Trial Update: Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer [NA]

View source ↗

Summary

Mayo Clinic is recruiting for a study evaluating adaptive radiation therapy with stereotactic ablative body radiotherapy for primary localized prostate cancer a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Localized Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 | NA | Status: RECRUITING